BRCA2, exon 27 (Breast Cancer Susceptibility Protein 2, Early Onset, FANCB, Fanconi Anemia, Complementation Group B, FANCD1, Fanconi Anemia, Complementation Group D1)
|
|
BRCA2, exon 27 (Breast Cancer Susceptibility Protein 2, Early Onset, FANCB, Fanconi Anemia, Complementation Group B, FANCD1, Fanconi Anemia, Complementation Group D1) Eigenschaften
Sicherheit
BRCA2, exon 27 (Breast Cancer Susceptibility Protein 2, Early Onset, FANCB, Fanconi Anemia, Complementation Group B, FANCD1, Fanconi Anemia, Complementation Group D1) Chemische Eigenschaften,Einsatz,Produktion Methoden
BRCA2, exon 27 (Breast Cancer Susceptibility Protein 2, Early Onset, FANCB, Fanconi Anemia, Complementation Group B, FANCD1, Fanconi Anemia, Complementation Group D1) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
BRCA2, exon 27 (Breast Cancer Susceptibility Protein 2, Early Onset, FANCB, Fanconi Anemia, Complementation Group B, FANCD1, Fanconi Anemia, Complementation Group D1) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 1)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Advanced Technology & Industrial Co., Ltd. | -- |
sales@advtechind.com | China | 6523 | 75 |
- BRCA2, exon 27 (Breast Cancer Susceptibility Protein 2, Early Onset, FANCB, Fanconi Anemia, Complementation Group B, FANCD1, Fanconi Anemia, Complementation Group D1)